BCIQ Profiles

Company Profile ReportTarget Profile Report
0219 TIB preclin QT
BioCentury & Getty Images

Translation in Brief

mAb reduces amyloid plaques without hemorrhage; plus Dyno and Ally’s AAV technologies and more

BioCentury’s roundup of translational news

BioCentury’s roundup of translational news.

Feb 19, 2021 | 11:33 PM GMT

Alzheimer’s disease immunotherapy reduces β-amyloid without increasing brain bleeding
Published in Science Translational Medicine, Denali Therapeutics Inc. (NASDAQ:DNLI) and Washington University

Read the full 619 word article

How to gain access

Continue reading with a
two-week free trial.